Home|Journals|Articles by Year|Audio Abstracts
 

Original Article

ECB. 2015; 4(5): 249-259


PATHWAYS FOR THE SYNTHESIS OF PYRIMIDINE AND PYRAN BASED HETEROCYCLIC DERIVATIVES: A CONCISE REVIEW

Ayaz Mahmood Dar, Shamsuzzaman.




Abstract

Pyrimidines and pyrans are the special class of heterocyclic compounds with a broad spectrum of biological activities such as anticancer,
antiviral, antibacterial, antioxidant, antiallergic and antidepressant. The use of pyran derivatives is not only limitted in cosmetics, pigments
and biodegradable agrochemicals but also constitute a structural unit of many natural products. Therefore researchers have synthesized
these condensed heterocycles through different complex pathways as target structures for biological studies. This review focuses on the
various strategies followed for the convenient synthesis of pyrimidine and pyran based heterocyclic compounds. The steps included
condensation followed by cyclization or MCR, either in a step-wise manner or in one pot has been achieved successfully to obtain these
two classes of heterocycles under different conditions. Diethyl oxalate, diethyl malonate, malononitrile and ethyl cyanoacetate are the most
common reagents used for the synthesis of pyrimidines and pyrans appended on different heterocyclic skeletons.

Key words: heterocycles, pyrimidines, pyrans, diethyl malonate, malononitrile.






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.